'Quality, safety issues continue to haunt top firms in India'

'Quality, safety issues continue to haunt top firms in India'

Written by Deepak Patel | New Delhi | Published: June 22, 2018 12:16:04 am Commerce and Industry Minister Suresh Prabhu. (Express Photo by Prem Nath Pandey/File) Quality and safety issues “continue to haunt even the top companies” of the Indian pharmaceutical industry and there have been numerous instances of “data falsification”, “inadequate documentation” and “lax […]

Antibiotic supply chains need better management to fix shortage

Antibiotic supply chains need better management to fix shortage

Dive Brief: Recognizing the weaknesses of the antibiotic supply chain, the Access Medicine Foundation released a white paper outlining key ways to strengthen the supply chain and improve antibiotic access to patients. To fix shortages stemming from the low profit nature of the business, increasing demand, low production levels and an “oligopoly” of active pharmaceutical […]

Global Antibody Drug Conjugates Market Expected to Reach $3198 Million by 2023

Global Antibody Drug Conjugates Market Expected to Reach $3198 Million by 2023

     (Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg ) Antibody drug conjugates are highly powerful biopharmaceutical medications prepared by integrating two principles i.e. a cell killing highly powerful active pharmaceutical ingredient (HPAPI) and explicit nature of monoclonal antibodies. They are highly effective anticancer drugs targeting only cancer infected cells thus, leaving healthy uninfected cell intact facilitating quick recovery of cancer […]

RespireRx Takes Step to Advance Dronabinol Obstructive Sleep Apnea Program with Letter of Intent for Co …

RespireRx Takes Step to Advance Dronabinol Obstructive Sleep Apnea Program with Letter of Intent for Co …

On June 13, 2018, RespireRx Pharmaceuticals Inc entered into a letter of intent with Noramco Inc, a producer of controlled substances bulk APIs for the pharmaceutical industry, pursuant to which the parties have entered into a 90-day period during which they will negotiate a definitive agreement regarding the RespireRx’s development of dronabinol. Subject to successful […]

Active Pharmaceutical Ingredient Market to Expand at a Robust 6.4% CAGR by 2023

Active Pharmaceutical Ingredient Market to Expand at a Robust 6.4% CAGR by 2023

The global active pharmaceutical ingredients (API) market is prognosticated to showcase promising growth in the coming years, according to a report published by Transparency Market Research (TMR). The market features vendors that have gained expertise in specific technologies, and are operating with cutting edge specialization in their production capacities. Leading names in the industry are […]

Active Pharmaceutical Ingredients Market 2018; Relish Tremendous Growth at a CAGR of 4.93% | Achieve Share worth …

Active Pharmaceutical Ingredients Market 2018; Relish Tremendous Growth at a CAGR of 4.93% | Achieve Share worth …

“Active Pharmaceutical Ingredients Market” The report titled Global Active Pharmaceutical Ingredients Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover market size, growth rate, opportunities, market Dynamics and Factor Analysis. And also cover the other information such as Active Pharmaceutical Ingredients market trends, Top players, chapter-wise Description followed by […]

Fragile Antibiotic Supply Chains Are Leading to Frequent Shortages, Worsening Antimicrobial Resistance

Fragile Antibiotic Supply Chains Are Leading to Frequent Shortages, Worsening Antimicrobial Resistance

Antibiotic supply chains are fragile and at risk of collapsing, warns a new white paper from the Amsterdam-based Access to Medicine Foundation. Shortages of specific antibiotics are causing price hikes, delayed treatment and the prescription of lower doses or alternative antibiotics — which worsens the growing threat of antimicrobial resistance. Similar to the situation that […]

PROVECTUS BIOPHARMACEUTICALS EXPANDS GLOBAL PATENT PORTFOLIO FOR ACTIVE PHARMACEUTICAL …

PROVECTUS BIOPHARMACEUTICALS EXPANDS GLOBAL PATENT PORTFOLIO FOR ACTIVE PHARMACEUTICAL …

FOR IMMEDIATE RELEASE KNOXVILLE, TN, June 19, 2018 (GLOBE NEWSWIRE) — Provectus today announced that the Indian Patent Office (IPO) has granted the Company’s patent application for the synthetic process used to produce the active pharmaceutical ingredient (API) in PV-10, which is Provectus’ lead investigational oncology drug. The Company’s patent estate associated with API manufacturing […]

1 2 3 28